144 related articles for article (PubMed ID: 37526009)
1. A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78.
Shin J; Kim B; Lager TW; Mejia F; Guldner I; Conner C; Zhang S; Panopoulos AD; Bilgicer B
Nanoscale; 2023 Aug; 15(32):13322-13334. PubMed ID: 37526009
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78.
Miao YR; Eckhardt BL; Cao Y; Pasqualini R; Argani P; Arap W; Ramsay RG; Anderson RL
Clin Cancer Res; 2013 Apr; 19(8):2107-16. PubMed ID: 23470966
[TBL] [Abstract][Full Text] [Related]
3. Engineering peptide-targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy.
Kim B; Shin J; Wu J; Omstead DT; Kiziltepe T; Littlepage LE; Bilgicer B
J Control Release; 2020 Jun; 322():530-541. PubMed ID: 32276005
[TBL] [Abstract][Full Text] [Related]
4. Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway.
Zheng Y; Liu P; Wang N; Wang S; Yang B; Li M; Chen J; Situ H; Xie M; Lin Y; Wang Z
Oxid Med Cell Longev; 2019; 2019():8781690. PubMed ID: 31531187
[TBL] [Abstract][Full Text] [Related]
5. Biological evaluation of a novel stable peptide PET molecular probe [
Yao B; Wang L; Xie C; Li M; Peng C; Li Z; Lu W; Chen J
Nucl Med Biol; 2023; 118-119():108330. PubMed ID: 36889247
[TBL] [Abstract][Full Text] [Related]
6. Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer.
Farshbaf M; Khosroushahi AY; Mojarad-Jabali S; Zarebkohan A; Valizadeh H; Walker PR
J Control Release; 2020 Dec; 328():932-941. PubMed ID: 33129921
[TBL] [Abstract][Full Text] [Related]
7. Structure-based optimization of GRP78-binding peptides that enhances efficacy in cancer imaging and therapy.
Wang SH; Lee AC; Chen IJ; Chang NC; Wu HC; Yu HM; Chang YJ; Lee TW; Yu JC; Yu AL; Yu J
Biomaterials; 2016 Jul; 94():31-44. PubMed ID: 27088408
[TBL] [Abstract][Full Text] [Related]
8. Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling.
Lager TW; Conner C; Keating CR; Warshaw JN; Panopoulos AD
Oncogene; 2021 Jun; 40(23):4050-4059. PubMed ID: 33981001
[TBL] [Abstract][Full Text] [Related]
9. GRP78-targeted and doxorubicin-loaded nanodroplets combined with ultrasound: a potential novel theranostics for castration-resistant prostate cancer.
Zhao Y; Shi D; Shang M; Sun X; Guo L; Meng D; Liu X; Zhou X; Li J
Drug Deliv; 2022 Dec; 29(1):203-213. PubMed ID: 34985396
[TBL] [Abstract][Full Text] [Related]
10. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78.
Cai Y; Zheng Y; Gu J; Wang S; Wang N; Yang B; Zhang F; Wang D; Fu W; Wang Z
Cell Death Dis; 2018 May; 9(6):636. PubMed ID: 29802332
[TBL] [Abstract][Full Text] [Related]
11. The Glucose-Regulated Protein78 (GRP78) in the Unfolded Protein Response (UPR) Pathway: A Potential Therapeutic Target for Breast Cancer.
Sadeghipour MM; Torabizadeh SA; Karimabad MN
Anticancer Agents Med Chem; 2023; 23(5):505-524. PubMed ID: 36017846
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum chaperone GRP78/BiP is critical for mutant Kras-driven lung tumorigenesis.
Rangel DF; Dubeau L; Park R; Chan P; Ha DP; Pulido MA; Mullen DJ; Vorobyova I; Zhou B; Borok Z; Offringa IA; Lee AS
Oncogene; 2021 May; 40(20):3624-3632. PubMed ID: 33931739
[TBL] [Abstract][Full Text] [Related]
13. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis.
Fu Y; Li J; Lee AS
Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086
[TBL] [Abstract][Full Text] [Related]
14. Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity.
Hardy B; Raiter A; Yakimov M; Vilkin A; Niv Y
Cell Oncol (Dordr); 2012 Oct; 35(5):345-54. PubMed ID: 22945507
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy Controls Metastasis Through Stimulatory Effects on GRP78 and Its Transcription Factor CREB3L1.
Raiter A; Lipovetsky J; Hyman L; Mugami S; Ben-Zur T; Yerushalmi R
Front Oncol; 2020; 10():1500. PubMed ID: 33042795
[TBL] [Abstract][Full Text] [Related]
16. Cell-Penetrating Peptidic GRP78 Ligand-Conjugated Iron Oxide Magnetic Nanoparticles for Tumor-Targeted Doxorubicin Delivery and Imaging.
Hasani M; Jafari S; Akbari Javar H; Abdollahi H; Rashidzadeh H
ACS Appl Bio Mater; 2023 Mar; 6(3):1019-1031. PubMed ID: 36862384
[TBL] [Abstract][Full Text] [Related]
17. Cell surface GRP78 promotes stemness in normal and neoplastic cells.
Conner C; Lager TW; Guldner IH; Wu MZ; Hishida Y; Hishida T; Ruiz S; Yamasaki AE; Gilson RC; Belmonte JCI; Gray PC; Kelber JA; Zhang S; Panopoulos AD
Sci Rep; 2020 Feb; 10(1):3474. PubMed ID: 32103065
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy.
Shim N; Jeon SI; Yang S; Park JY; Jo M; Kim J; Choi J; Yun WS; Kim J; Lee Y; Shim MK; Kim Y; Kim K
Biomaterials; 2022 Oct; 289():121806. PubMed ID: 36156411
[TBL] [Abstract][Full Text] [Related]
19. Citrullinated glucose-regulated protein 78 is a candidate target for melanoma immunotherapy.
Brentville VA; Symonds P; Chua J; Skinner A; Daniels I; Cook KW; Koncarevic S; Martinez-Pinna R; Shah S; Choudhury RH; Vaghela P; Weston D; Al-Omari A; Davis J; Durrant LG
Front Immunol; 2022; 13():1066185. PubMed ID: 36544781
[TBL] [Abstract][Full Text] [Related]
20. GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78.
Delie F; Petignat P; Cohen M
Target Oncol; 2013 Dec; 8(4):225-30. PubMed ID: 23090204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
